Stock screenerAll disclosures →
EDGAR →
GERN
Conviction 18HealthcareScan · Thu, Jun 25, 2026GERN$1.37-1.44%
ResistanceSupportVol 14Vol MA14 14.83M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price1.37
Change-1.44%
Gap-0.36%
Rel volume0.79×
Avg volume13.54M
Avg $ vol16.52M
SMA 201.22
SMA 501.36
SMA 2001.39
Price vs 50+0.38%
Price vs 200-1.58%
MA stackmixed
50/200 crossdeath · 3d
Supertrendup · 1.18
RSI (14)61
MACD hist0.04
MACD crossbull · 8d
Stoch %K / %D74 / 83
ADX (14)25
+DI / −DI34 / 13
RSI divergence—
MACD divergenceBullish
ATR %+5.65%
ADR %5.71%
52w high1.95
52w low1.07
From 52w high-30.00%
Above 52w low+27.57%
New 52w highNo
SqueezeOff
Bollinger width27.70%
%B0.94
Donchian pos74.03%
Donchian high1.47
Donchian low1.08
AVWAP (52w high)1.52
vs AVWAP high-9.96%
AVWAP (52w low)1.47
vs AVWAP low-7.06%
OBV trendUp
Chaikin MF (20)-0.23
Today vs 20d0.79×
Avg vol (14d)14.83M
Avg vol (20d)13.54M
Avg $ vol (20d)16.52M
Market cap875.68M
RS 3m (vs SPY)-20.54%
RS 6m (vs SPY)-3.60%
RS line new highNo
Trend template2/8
Technical rank54.1
1 week+10.98%
1 month+6.64%
3 months-13.06%
6 months+1.11%
1 year-11.94%
YTD+3.41%
P/E-10.49
P/B3.82
P/S—
P/FCF-7.84
EPS-0.1300
Div yield—
ROE-36.45%
ROA-15.63%
Debt/Eq0.84
Current6.78
EV/EBITDA-14.66
Gross margin—
Net margin—
Rev growth-60.23%
EPS growth52.17%
Price target4.00
Target upside193.04%
Analyst ratingBuy
Institutional83.18%
Ent. value998.18M
Revenue51.84M
Net income-3.64M
Gross profit—
Free cash flow-111.72M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out641.52M
Employees258
ListedWed, Jul 31, 1996
Free float625.8M
Float %97.6%
Short interest71.77M
Days to cover7.6d
Short volume46.6%
Squeeze score52 / 100
Next earningsWed, Aug 5, 2026 (41d)
EPS forecast−$0.01 · 3 est
Last EPS vs est−$0.01 vs −$0.03
Last surprise+66.7% beat
Setup gradeD
Conviction18 / 100
Pattern quality—
Tech rank54.1 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.52
Support1.11
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in GERN
No recent disclosed trades by Congress in GERN. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in GERN · 6 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Bir Dawn Carter Director · Stock Option (right to buy) · 2026-05-20 | Grant | 220K | $0 | 2026-05-20 | 2026-05-26 |
O'Farrell Elizabeth G. Director · Stock Option (right to buy) · 2026-05-20 | Grant | 220K | $0 | 2026-05-20 | 2026-05-26 |
Molineaux Susan Director · Stock Option (right to buy) · 2026-05-20 | Grant | 220K | $0 | 2026-05-20 | 2026-05-26 |
Spiegel Robert J. Director · Stock Option (right to buy) · 2026-05-20 | Grant | 220K | $0 | 2026-05-20 | 2026-05-26 |
McDonald John F Director · Stock Option (right to buy) · 2026-05-20 | Grant | 220K | $0 | 2026-05-20 | 2026-05-26 |
Williams Timothy EVP and Chief Legal Officer · Stock Option (Right to Buy) · 2026-04-13 | Grant | 2.5M | $0 | 2026-04-13 | 2026-04-14 |
SEC filings
EDGAR filings in GERN
No recent SEC filings on file for GERN.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.